• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶D缺乏症(CLN10)的新型突变及首次产前筛查

Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10).

作者信息

Fritchie Karen, Siintola Eija, Armao Diane, Lehesjoki Anna-Elina, Marino Thomas, Powell Cynthia, Tennison Michael, Booker Jessica M, Koch Sabine, Partanen Sanna, Suzuki Kinuko, Tyynelä Jaana, Thorne Leigh B

机构信息

Department of Pathology and Laboratory Medicine, UNC-Chapel Hill, Chapel Hill, NC 27514, USA.

出版信息

Acta Neuropathol. 2009 Feb;117(2):201-8. doi: 10.1007/s00401-008-0426-7. Epub 2008 Sep 2.

DOI:10.1007/s00401-008-0426-7
PMID:18762956
Abstract

The neuronal ceroid lipofuscinoses (NCLs) are autosomal recessively inherited disorders collectively considered to be one among the most common pediatric neurodegenerative lysosomal storage diseases. Four main clinical subtypes have been described based on the age at presentation: infantile, late infantile, juvenile and adult types. In addition, rare congenital cases of NCL have been reported in the literature. Previously, a homozygous mutation in the cathepsin D gene has been shown to cause congenital NCL in a patient of Pakistani origin. We report a case of a 39-week estimated gestational age female infant with severe microcephaly and hypertonia, whereas MRI showed generalized hypoplasia of the cerebral and cerebellar hemispheres. The infant died on day two after birth. Postmortem examination revealed a small, firm brain with extensive neuronal loss and gliosis. Remaining neurons, astrocytes and macrophages contained PAS-positive storage material with granular ultrastructure and immunoreactivity against sphingolipid activator protein D. A diagnosis of congenital NCL was rendered with a novel mutation, c.299C > T (p.Ser100Phe) in exon 3 of the cathepsin D gene. In the patient fibroblasts, cathepsin D activity was marginal, but the protein appeared stable and normally processed. This was confirmed in overexpression studies. Importantly, by identification of the mutation in the family, we were able to confirm the first prenatal diagnosis excluding cathepsin D deficiency in the younger sibling of the patient.

摘要

神经元蜡样脂褐质沉积症(NCLs)是常染色体隐性遗传疾病,被公认为是最常见的儿科神经退行性溶酶体贮积病之一。根据发病年龄已描述了四种主要临床亚型:婴儿型、晚婴儿型、青少年型和成人型。此外,文献中还报道了罕见的先天性NCL病例。此前,已证明组织蛋白酶D基因的纯合突变可导致一名巴基斯坦裔患者出现先天性NCL。我们报告了一例估计孕龄39周的女婴,患有严重小头畸形和张力亢进,而磁共振成像(MRI)显示大脑和小脑半球普遍发育不全。该婴儿在出生后第二天死亡。尸检显示大脑小而硬,有广泛的神经元丢失和胶质增生。剩余的神经元、星形胶质细胞和巨噬细胞含有PAS阳性贮积物质,具有颗粒状超微结构且对鞘脂激活蛋白D有免疫反应性。通过组织蛋白酶D基因第3外显子的一个新突变c.299C>T(p.Ser100Phe)作出了先天性NCL的诊断。在患者成纤维细胞中,组织蛋白酶D活性微弱,但该蛋白似乎稳定且加工正常。这在过表达研究中得到了证实。重要的是,通过鉴定该家族中的突变基因,我们得以确诊首例产前诊断,排除了患者年幼同胞的组织蛋白酶D缺乏症。

相似文献

1
Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10).组织蛋白酶D缺乏症(CLN10)的新型突变及首次产前筛查
Acta Neuropathol. 2009 Feb;117(2):201-8. doi: 10.1007/s00401-008-0426-7. Epub 2008 Sep 2.
2
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.组织蛋白酶D缺乏是人类先天性神经元蜡样脂褐质沉积症的基础。
Brain. 2006 Jun;129(Pt 6):1438-45. doi: 10.1093/brain/awl107. Epub 2006 May 2.
3
Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses.组织蛋白酶D缺陷型果蝇概括了神经元蜡样脂褐质沉积症的关键特征。
Neurobiol Dis. 2005 Jun-Jul;19(1-2):194-9. doi: 10.1016/j.nbd.2004.12.019.
4
Genetic modifiers of degeneration in the cathepsin D deficient Drosophila model for neuronal ceroid lipofuscinosis.神经鞘脂褐质沉积病的组织蛋白酶 D 缺陷型果蝇模型中变性的遗传修饰物。
Neurobiol Dis. 2009 Dec;36(3):488-93. doi: 10.1016/j.nbd.2009.09.001. Epub 2009 Sep 15.
5
Developmental changes in the expression of neuronal ceroid lipofuscinoses-linked proteins.神经元蜡样脂褐质沉积症相关蛋白表达的发育变化
Mol Genet Metab. 2000 Sep-Oct;71(1-2):190-4. doi: 10.1006/mgme.2000.3071.
6
First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis.使用PPT酶测定法和CLN1基因突变分析对婴儿神经元蜡样脂褐质沉积症(INCL)进行孕早期诊断。
Prenat Diagn. 1999 Jun;19(6):559-62.
7
A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis.患有神经元蜡样脂褐质沉积症的美国斗牛犬组织蛋白酶D基因(CTSD)中的一种突变。
Mol Genet Metab. 2006 Apr;87(4):341-8. doi: 10.1016/j.ymgme.2005.11.005. Epub 2006 Jan 4.
8
Prenatal-onset of congenital neuronal ceroid lipofuscinosis with a novel CTSD mutation.先天性神经元蜡样脂褐质沉积症伴新型 CTSD 突变的产前发病。
Birth Defects Res. 2021 Nov;113(18):1324-1332. doi: 10.1002/bdr2.1950. Epub 2021 Sep 7.
9
Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis.新型 CLN8 突变证实了晚发性婴儿神经元蜡样脂褐质沉积症的临床和种族多样性。
Clin Genet. 2010 Jan;77(1):79-85. doi: 10.1111/j.1399-0004.2009.01285.x. Epub 2009 Oct 5.
10
Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis.CLN6基因的新型突变导致变异型晚发性婴儿神经元蜡样脂褐质沉积症。
Hum Mutat. 2003 May;21(5):502-8. doi: 10.1002/humu.10207.

引用本文的文献

1
Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy.溶酶体肽酶在生理和病理条件下的非经典、溶酶体外活性:癌症治疗的新临床机遇
Cells. 2025 Jan 7;14(2):68. doi: 10.3390/cells14020068.
2
Impacts of hnRNP A1 Splicing Inhibition on the Brain Remyelination Proteome.异质性核糖核蛋白A1剪接抑制对脑再髓鞘化蛋白质组的影响。
J Neurochem. 2025 Jan;169(1):e16304. doi: 10.1111/jnc.16304.
3
Biomarkers in Ataxia-Telangiectasia: a Systematic Review.共济失调毛细血管扩张症中的生物标志物:一项系统综述
J Neurol. 2025 Jan 15;272(2):110. doi: 10.1007/s00415-024-12766-7.
4
Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in and Sporadic Frontotemporal Lobar Degeneration.血浆中小细胞外囊泡组织蛋白酶 D 在家族性和散发性额颞叶痴呆中的失调。
Int J Mol Sci. 2022 Sep 14;23(18):10693. doi: 10.3390/ijms231810693.
5
Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.神经元蜡样脂褐质沉积症的遗传基础、临床特征和诊断方法的最新研究进展。
Int J Mol Sci. 2022 May 20;23(10):5729. doi: 10.3390/ijms23105729.
6
: A Model System for Neurological Disorders.神经系统疾病模型系统。
Cells. 2022 Jan 28;11(3):463. doi: 10.3390/cells11030463.
7
The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease.CTSD 基因 c.863A>G(p.Glu288Gly)变异与 CLN10 病无关。
Mol Genet Genomic Med. 2021 Oct;9(10):e1777. doi: 10.1002/mgg3.1777. Epub 2021 Jul 31.
8
Cathepsin D-Managing the Delicate Balance.组织蛋白酶D——维持微妙平衡
Pharmaceutics. 2021 Jun 5;13(6):837. doi: 10.3390/pharmaceutics13060837.
9
Rapid and Progressive Loss of Multiple Retinal Cell Types in Cathepsin D-Deficient Mice-An Animal Model of CLN10 Disease.组织蛋白酶 D 缺乏型小鼠中多种视网膜细胞类型的快速进行性丧失——CLN10 病的动物模型。
Cells. 2021 Mar 21;10(3):696. doi: 10.3390/cells10030696.
10
Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties.与神经退行性疾病相关的组织蛋白酶D变体表现出功能失调和α-突触核蛋白降解特性改变。
Front Cell Dev Biol. 2021 Feb 11;9:581805. doi: 10.3389/fcell.2021.581805. eCollection 2021.